ERIDANUS HEALTHCARE
Established in 1994, Eridanus Healthcare, Inc. started as a generic drug manufacturer, and today while venturing into IND development—continues to manufacture and market these products through our global network of distributors. Eridanus Healthcare entered the contract development & manufacturing arena in 2000. As a CDMO, Stason provides product development and manufacturing support to other pharmaceutical companies. Our specialty is high containment manufacturing at commercial scales. In 2008, we launched our Brand Division when we obtained exclusive development and commercialization rights to novel proprietary compounds in the area of oncology. For more information click here In 2014, we established our sales & marketing division, which has captured a significant market share for each product. We expect to launch several products per year, including authorized generics, injectables, and 505(b)(2) Ongoing expansion projects include: the establishment of dedicated business development offices in the US & Canada, laboratories in Kansas, a logistics center for distribution in North America, launch of consumer healthcare division, and construction of a pilot plant for expansion of our product development capabilities. ( OUR MISSION ) :- Our administration and representative workforce are focused on effectively sending our organization's Quality Policy to all parts of our firm-guaranteeing proceeded with great, protected and viable. ( OUR VISION ) :- Creative help to clinical society for better patient consideration. After effective assistance in eye care we are presently making a beeline for be a finished human services supplier with quality medicines. ( OUR VALUES ) :- Eridanus Healthcare tries to make a more advantageous world. Its key vision of "More and More with Less and Less" has changed into better approaches for deduction, another excursion for development, world class quality medicines.
